CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Enhanced Recovery pathwayother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02584322
NCT02584322N/ACompleted
CompareCT.gov

Fast Tracking in VATS Lobectomy: A Prospective, Historically Controlled, Propensity-Matched Clinical Trial

Centre hospitalier de l'Université de Montréal (CHUM)·interventional·Posted Oct 22, 2015·Updated Sep 1, 2017

In Brief

A clinical study evaluating Enhanced Recovery pathway for Lung Cancer. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Currently, at the CHUM - Notre-Dame Hospital, there is no standardized patient care pathway for patients undergoing Video Assisted Thoracic Surgery (VATS) lobectomy. The investigators goal is to implement an Enhanced Recovery Program (ERP) for patient undergoing VATS lobectomy. The care given to patient prior to the implementation of this protocol was different amongst patients and depended on the surgeon's preferences. The implementation of this ERP will permit a reproducible and routine management for patients following their surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesCanada
CollaboratorsCentre de Recherche du Centre Hospitalier de l'Université de Montréal

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 22, 2015
Enrollment StartNov 1, 2015
Primary CompletionNov 1, 2016
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 10.7 years ago

Interventions

Enhanced Recovery pathwayother

The enhanced recovery pathway consists of postoperative medical orders including nursing care, investigations and tests, and other peri-operative orders. The enhanced recovery pathway is standardized for all patients, and can be discontinued at any time when clinical judgment mandates (i.e. patient has a severe complication).